In another study on the role of EZH2 in breast cancer cisplatin resistance, it was shown that Salvianolic acid B promoted vascular normalization in mouse models of breast cancer, which subsequently improved drug delivery and response to cisplatin. Here, EZH2 is linked to breast carcinoma.